Aptargroup, Inc DEFR14A, filed Apr 10, 2023
Aptargroup, Inc. (ATR)
DEFR14A
2023-04-10
View Original
Added on
October 23, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No. 1)
Filed by the Registrant ☒ | |||||
Filed by a Party other than the Registrant ☐ | |||||
| Check the appropriate box: | |||||
| ☐ | Preliminary Proxy Statement | ||||
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||||
| ☒ | Definitive Proxy Statement | ||||
| ☐ | Definitive Additional Materials | ||||
| ☐ | Soliciting Material under §240.14a-12 | ||||
| AptarGroup, Inc. | |||||||||||
| (Name of Registrant as Specified In Its Charter) | |||||||||||
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) | |||||||||||
| Payment of Filing Fee (Check all boxes that apply): | |||||||||||
| ☒ | No fee required. | ||||||||||
| ☐ | Fee paid previously with preliminary materials. | ||||||||||
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. | ||||||||||
Supplement to the Proxy Statement Dated March 24, 2023
for the Annual Meeting of Stockholders to be Held on May 3, 2023
April 10, 2023
On March 24, 2023, AptarGroup, Inc. (“Aptar”) filed a definitive Proxy Statement on Schedule 14A (the “Proxy Statement”) in connection with its 2023 annual meeting of stockholders to be held on May 3, 2023 (the “Annual Meeting”). At the Annual Meeting, the Company is requesting that the stockholders of the Company approve an amendment to the AptarGroup, Inc. 2018 Equity Incentive Plan (“2018 Plan”), as set forth in Proposal No. 4 of the Proxy Statement.
After distributing the Proxy Statement, Aptar approved an update to the proposed amendment to the 2018 Plan to decrease the number of new shares of Aptar common stock (the “Common Stock”) authorized for issuance under the 2018 Plan from 1,300,000 to 1,200,000 shares, thereby reducing the aggregate number of shares of Common Stock authorized for future issuance under the 2018 Plan from 2,006,658 shares to 1,906,658 shares (including the 706,658 shares that remained available for future issuances under the 2018 Plan as of March 10, 2023). Based on this update, the maximum number of shares of Common Stock authorized to be issued under the proposed amendment to the 2018 Plan will increase from 1,950,000 to 3,150,000, instead of 3,250,000 as previously disclosed in the Proxy Statement. Other than the change described above, all other terms of the 2018 Plan, as proposed to be amended, remain the same as those described in the Proxy Statement. Please see Proposal No. 4 in the Proxy Statement for further information regarding the 2018 Plan.
Marked Change to Section 4 of the 2018 Plan
As updated, the proposed amendment to Section 4 of the 2018 Plan is as marked below.
4. Shares Subject to Plan Subject to adjustment as provided in Section 7(b) and to all other limits set forth in this Plan, the number of shares of Common Stock that shall initially be available for all Awards under this Plan shall be 3,250,000 3,150,000 (reduced by the number of shares of Common Stock subject to awards granted under the Prior Plan on or after March 31, 2018), all of which may be issued under the Plan in connection with ISOs (as defined in Section 6(a)). The number of shares of Common Stock that remain available for future grants under the Plan shall be reduced by the sum of the aggregate number of shares of Common Stock which become subject to Awards. To the extent that shares of Common Stock subject to an outstanding award granted under either this Plan or a Prior Plan are not issued or delivered by reason of (i) the expiration, termination, cancellation or forfeiture of such award (except in the case of an option to the extent shares of Common Stock are issued or delivered by the Company in connection with the exercise of a tandem SAR) or (ii) the cash settlement of such award, then such shares of Common Stock shall again be available under this Plan. Shares of Common Stock shall not again be available under the Plan (i) if tendered to satisfy all or a portion of tax withholding obligations relating to such Award, (ii) if such shares were subject to an option or stock-settled SAR and were not issued or delivered upon the net settlement or net exercise of such option of SARs (iii) if withheld to pay the exercise price of stock options or SARs awarded hereunder or (iv) if repurchased by the Company on the open market with the proceeds of an option exercise. The number of shares that again become available pursuant to this paragraph shall be equal to one share for each share subject to an Award described herein; provided, however, any shares from a Prior Plan that become available under this Plan pursuant to this paragraph shall be added to this Plan based on the share deduction ratio set forth in such Prior Plan. At the time this Plan becomes effective, none of the shares of Common Stock available for future grant under any Prior Plan shall be available for grant under such Prior Plan.
The number of shares of Common Stock available for Awards under this Plan shall not be reduced by (i) the number of shares of Common Stock subject to Substitute Awards or (ii) available shares under a stockholder approved plan of a company or other entity which was a party to a corporate transaction with the Company (as appropriately adjusted to reflect such corporate transaction) which become subject to Awards granted under this Plan (subject to applicable stock exchange requirements).
The aggregate value of cash compensation and the grant date fair value of shares of Common Stock that may be awarded or granted during any fiscal year of the Company to any non-employee director shall not exceed $500,000; provided, however, that the limit set forth in this sentence shall be multiplied by two in the year in which a non-employee director commences service on the Board of Directors. Shares of Common Stock available under the Plan may be treasury shares reacquired by the Company or authorized and unissued shares, or a combination of both.
The proposed amendments to the 2018 Plan, as updated by this Supplement, will be presented for stockholder approval at the Annual Meeting and its effectiveness remains conditioned on the receipt of such approval. Stockholders who have already voted need not take any action but may, if they wish, change or revoke their vote by following the instructions described on page 84 of the Proxy Statement.